Ovarian hormones influence eating disorder symptom variability during the menopause transition: A pilot study
Baker et al.
The finding, in our words
In a pilot of eight perimenopausal women, daily self-collected saliva assays and online symptom questionnaires showed that progesterone modifies estradiol’s association with binge eating and body dissatisfaction, broadly aligning with data from younger women. This demonstrates that decentralised hormone monitoring can capture clinically relevant symptom fluctuations, supporting the feasibility of remote studies in midlife women.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
In a study of 46 perinatal nicotine users, dried blood spots and saliva were used weekly to measure reproductive hormones, finding that lower postpartum estradiol and greater peripartum declines in oxytocin were associated with increased nicotine craving and use. This demonstrates the feasibility of decentralised microsampling and remote surveys for longitudinal hormone tracking in vulnerable populations.
Only 24% of participants completed this two-cycle feasibility study of AI-interpreted salivary ferning for ovulation prediction in females with irregular cycles, with 44% withdrawing citing cycle irregularity, pregnancy, or time constraints. The authors concluded that decentralised fertility trials must streamline procedures and provide ovulatory health education to improve retention and reduce burden before smartphone-based diagnostics can be scaled for this population.
This study used home self-collected saliva samples to successfully monitor cytokines and cortisol in mothers and infants, finding that a community singing intervention significantly reduced salivary interleukin-6 levels in mothers with postnatal depression.
Self-collected salivary progesterone and the ratio of estradiol to progesterone showed strong agreement with serum levels, supporting the use of saliva as a noninvasive matrix for monitoring the menstrual cycle.
In female shift workers, 0.3 mg melatonin reduced climacteric symptoms by 15.8% compared with placebo and improved sleep quality on days off by 35.33%, with no shift interaction; home blood sampling enabled measurement of LH, FSH, estradiol and progesterone.